PHAR vs GYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

PHAR

41.3
AI Score
VS
GYRE Wins

GYRE

45.3
AI Score

Investment Advisor Scores

PHAR

41score
Recommendation
HOLD

GYRE

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR GYRE Winner
Forward P/E 204.0816 78.125 GYRE
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 2.1% GYRE
Earnings Growth -62.9% 166.2% GYRE
Tradestie Score 41.3/100 45.3/100 GYRE
Profit Margin 2.5% -5.4% PHAR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: -12.9% · 3M: -31.9% GYRE 1M: +11.8% · 3M: -2.1%

Current Technical Phase

PHAR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 34

RSI (14): 33.8 · Price: $9.75

GYRE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 52

RSI (14): 52.0 · Price: $7.11

Fundamentals Snapshot

Metric PHAR GYRE
Market Cap — —
Forward P/E 31.8 -30.3
Trailing P/E 71.1 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.9% 0.9%
Operating Margin 0.0% -0.5%
EPS 0.14 -0.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.